You just read:

Ionis Pharmaceuticals Announces The Initiation Of A Clinical Study Of Its First Orally Delivered Antisense Drug For The Treatment Of Gastrointestinal Disorders

News provided by

Ionis Pharmaceuticals, Inc.

Dec 21, 2017, 07:00 ET